Glen Harbor Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Glen Harbor Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$6K	Buy	+578	New	+$7.09K	﹤0.01%	1324

Other funds holding MIRM

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Glen Harbor Capital Management's MIRM Position: Q3 2019 in Review

Glen Harbor Capital Management opened a new position in Mirum Pharmaceuticals (MIRM) in Q3 2019: 578 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #1324 among its holdings.

39 funds tracked by Wall St. Rank hold MIRM as of Q3 2019.

Glen Harbor Capital Management held 578 shares of Mirum Pharmaceuticals worth $6K as of Q3 2019.
Mirum Pharmaceuticals was a new Glen Harbor Capital Management position in Q3 2019.
Mirum Pharmaceuticals made up ﹤0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #1324 holding.
39 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.